The global lung cancer screening software market size is estimated to reach USD 37.92 million by 2025 expanding at a CAGR of 19.5% from 2019 to 2025, according to a new report by Grand View Research, Inc. Growing incidence of lung cancer and rise in implementation of lung cancer screening programs across the globe are some of the significant factors driving the market growth. According to Globocan estimates, about 160,068 new cases of lung cancer were reported in South East Asian region in 2018.
A
number of clinical trials, studies, and demonstration projects are being
conducted around the world to evaluate the effectiveness of lung cancer
screening programs. For instance, in 2017, Cancer Care Ontario launched a
screening pilot trial for people at high risk. Favorable government initiatives
for successful implementation of such programs and increasing awareness about
the disease screening are also likely to contribute to the market growth in the
coming years.
Lung
cancer screening programs are widely adopted by hospitals and radiological
centers in U.S. However, they are usually performed as a part of national or
provisional screening program outside the country. In case of Latin America and
Middle Eastern countries, limited availability of resources, restricted
funding, low awareness levels, and lack of trained personnel are some of the
factors that impede market growth.
For more info visit here: https://www.grandviewresearch.com/industry-analysis/lung-cancer-screening-software-market
Lung Cancer
Screening Software Market Report Highlights
- In 2018,
North America accounted for the highest revenue share owing to various
lung cancer screening programs and favorable reimbursement scenario in the
region
- Asia Pacific
is expected to be the fastest-growing regional market over the forecast
period
- This is
attributed to the increasing cases of lung cancer and rise in the number
of screening trials & studies for the disease
- Nuance
Communications, Inc.; Eon; Koninklijke Philips N.V.; Siemens Healthineers
AG; PenRad Technologies, Inc.; MRS Systems, Inc.; and Magview are some of
the key companies in the market
Request a Sample Copy @ https://www.grandviewresearch.com/industry-analysis/lung-cancer-screening-software-market/request/rs1
Lung Cancer
Screening Software Market Segmentation
Grand View Research has
segmented the global lung cancer screening software market on the basis of
region:
Lung Cancer
Screening Software Regional Outlook (Revenue, USD Thousand, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Asia Pacific
- Japan
- China
- Australia
- Latin America
- Brazil
- Mexico
- MEA
- South Africa
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment